MX9800945A - Uso de griseofulvina para inhibir el crecimiento de canceres. - Google Patents
Uso de griseofulvina para inhibir el crecimiento de canceres.Info
- Publication number
- MX9800945A MX9800945A MX9800945A MX9800945A MX9800945A MX 9800945 A MX9800945 A MX 9800945A MX 9800945 A MX9800945 A MX 9800945A MX 9800945 A MX9800945 A MX 9800945A MX 9800945 A MX9800945 A MX 9800945A
- Authority
- MX
- Mexico
- Prior art keywords
- griseofulvin
- cancers
- inhibiting
- growth
- conjunction
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Se describe una composicion farmacéutica para el tratamiento de cánceres o tumores en mamíferos, la cual comprende griseofulvina. Se puede usar un agente quimioterapéutico en union con la griseofulvina como pueda ser los potenciadores. También se puede usar la griseofulvina para tratar infecciones virales, ya sea sola o en union con otros agentes virales o con un potenciador.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US183995P | 1995-08-03 | 1995-08-03 | |
US001839 | 1995-08-03 | ||
US67418196A | 1996-07-16 | 1996-07-16 | |
US674181 | 1996-07-16 | ||
PCT/US1996/012475 WO1997005870A2 (en) | 1995-08-03 | 1996-07-30 | Use of griseofulvin for inhibiting the growth of cancers |
Publications (2)
Publication Number | Publication Date |
---|---|
MXPA98000945A MXPA98000945A (es) | 1998-04-01 |
MX9800945A true MX9800945A (es) | 1998-04-30 |
Family
ID=26669547
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9800945A MX9800945A (es) | 1995-08-03 | 1996-07-30 | Uso de griseofulvina para inhibir el crecimiento de canceres. |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0841914A2 (es) |
JP (1) | JPH11511136A (es) |
KR (1) | KR19990036137A (es) |
AR (1) | AR003176A1 (es) |
AU (1) | AU713031B2 (es) |
BR (1) | BR9609920A (es) |
CA (1) | CA2228503A1 (es) |
CZ (1) | CZ30598A3 (es) |
HU (1) | HUP9903506A3 (es) |
IL (1) | IL123094A0 (es) |
MX (1) | MX9800945A (es) |
NO (1) | NO980420L (es) |
PL (1) | PL324905A1 (es) |
SK (1) | SK14298A3 (es) |
TR (1) | TR199800244T2 (es) |
WO (1) | WO1997005870A2 (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6479526B1 (en) | 1995-04-12 | 2002-11-12 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of viruses and cancers |
US6262093B1 (en) | 1995-04-12 | 2001-07-17 | The Proctor & Gamble Company | Methods of treating cancer with benzimidazoles |
US6177460B1 (en) | 1995-04-12 | 2001-01-23 | The Procter & Gamble Company | Method of treatment for cancer or viral infections |
US5770616A (en) | 1995-06-07 | 1998-06-23 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of cancers |
US6265427B1 (en) | 1995-06-07 | 2001-07-24 | The Proctor & Gamble Company | Pharmaceutical composition for the method of treating leukemia |
US6686391B2 (en) | 1995-08-04 | 2004-02-03 | University Of Arizona Foundation | N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions |
US5900429A (en) | 1997-01-28 | 1999-05-04 | The Procter & Gamble Company | Method for inhibiting the growth of cancers |
US6506783B1 (en) | 1997-05-16 | 2003-01-14 | The Procter & Gamble Company | Cancer treatments and pharmaceutical compositions therefor |
US6245789B1 (en) | 1998-05-19 | 2001-06-12 | The Procter & Gamble Company | HIV and viral treatment |
DK1098641T3 (en) * | 1998-07-27 | 2016-08-15 | St Jude Pharmaceuticals Inc | Chemically induced intracellular hyperthermia |
ES2543819T3 (es) * | 1998-11-09 | 2015-08-24 | Biogen Inc. | Tratamiento de neoplasias hematológicas asociadas con células tumorales circulantes utilizando anticuerpo quimérico dirigido contra CD20 |
US6423734B1 (en) | 1999-08-13 | 2002-07-23 | The Procter & Gamble Company | Method of preventing cancer |
US6608096B1 (en) | 2000-09-26 | 2003-08-19 | University Of Arizona Foundation | Compounds and methods for use thereof in the treatment of cancer or viral infections |
US6462062B1 (en) | 2000-09-26 | 2002-10-08 | The Procter & Gamble Company | Compounds and methods for use thereof in the treatment of cancer or viral infections |
US6380232B1 (en) | 2000-09-26 | 2002-04-30 | The Procter & Gamble Company | Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof |
US6407105B1 (en) | 2000-09-26 | 2002-06-18 | The Procter & Gamble Company | Compounds and methods for use thereof in the treatment of cancer or viral infections |
CN1543356B (zh) * | 2001-06-25 | 2011-09-28 | 味之素株式会社 | 抗肿瘤剂 |
EP2008652A1 (en) * | 2007-06-28 | 2008-12-31 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering |
EP2204367A1 (en) | 2008-12-22 | 2010-07-07 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering |
-
1996
- 1996-07-30 TR TR1998/00244T patent/TR199800244T2/xx unknown
- 1996-07-30 CA CA002228503A patent/CA2228503A1/en not_active Abandoned
- 1996-07-30 CZ CZ98305A patent/CZ30598A3/cs unknown
- 1996-07-30 PL PL96324905A patent/PL324905A1/xx unknown
- 1996-07-30 AU AU66834/96A patent/AU713031B2/en not_active Ceased
- 1996-07-30 EP EP96926807A patent/EP0841914A2/en not_active Withdrawn
- 1996-07-30 KR KR1019980700805A patent/KR19990036137A/ko not_active Application Discontinuation
- 1996-07-30 HU HU9903506A patent/HUP9903506A3/hu unknown
- 1996-07-30 IL IL12309496A patent/IL123094A0/xx unknown
- 1996-07-30 MX MX9800945A patent/MX9800945A/es unknown
- 1996-07-30 SK SK142-98A patent/SK14298A3/sk unknown
- 1996-07-30 JP JP9508495A patent/JPH11511136A/ja active Pending
- 1996-07-30 WO PCT/US1996/012475 patent/WO1997005870A2/en not_active Application Discontinuation
- 1996-07-30 BR BR9609920A patent/BR9609920A/pt unknown
- 1996-08-02 AR ARP960103861A patent/AR003176A1/es not_active Application Discontinuation
-
1998
- 1998-01-30 NO NO980420A patent/NO980420L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL123094A0 (en) | 1998-09-24 |
TR199800244T2 (xx) | 1998-09-21 |
NO980420D0 (no) | 1998-01-30 |
WO1997005870A2 (en) | 1997-02-20 |
AR003176A1 (es) | 1998-07-08 |
PL324905A1 (en) | 1998-06-22 |
JPH11511136A (ja) | 1999-09-28 |
WO1997005870A3 (en) | 1997-04-17 |
CZ30598A3 (cs) | 1998-06-17 |
HUP9903506A2 (hu) | 2000-06-28 |
CA2228503A1 (en) | 1997-02-20 |
SK14298A3 (en) | 1998-09-09 |
EP0841914A2 (en) | 1998-05-20 |
AU713031B2 (en) | 1999-11-18 |
NO980420L (no) | 1998-04-03 |
HUP9903506A3 (en) | 2000-07-28 |
BR9609920A (pt) | 1999-07-06 |
KR19990036137A (ko) | 1999-05-25 |
AU6683496A (en) | 1997-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9800945A (es) | Uso de griseofulvina para inhibir el crecimiento de canceres. | |
AP1553A (en) | Tricyclic inhibitors of poly (ADP-Ribose) polymerases. | |
UA39158C2 (uk) | Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі | |
MY133996A (en) | Compounds for the treatment of ischemia | |
MY132705A (en) | Novel compounds with analgesic effect | |
BG102600A (en) | Carbamoyloxy derivatives of mutilin and their use as bactericides | |
GEP20063885B (en) | Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use | |
NZ507350A (en) | Semi-synthetic ecteinascidins and use in treatment of tumors | |
MY116478A (en) | Tri-substituted imidazoles having multiple therapeutic properties | |
BG103947A (en) | Derivatives of 9-oxymerythromycin | |
CA2292359A1 (en) | Novel azalides and methods of making same | |
ZA9710796B (en) | Oxyiminopregnanecarbolactones. | |
MX9800998A (es) | Uso de fluconazol para inhibir el crecimiento de canceres. | |
UA41355C2 (uk) | Засіб для лікування нейро-сніду | |
BG102250A (en) | The use of marigold-extracted glycosides for the treatment of psoriasis | |
HUP0204449A3 (en) | Oncolytic combinations for the treatment of cancer, containing 2',2'-difluoronucleoside and leukotriene antagonist as active ingredients | |
AU4385399A (en) | Thiophene and furan 2,5-dicarboxamides useful in the treatment of cancer | |
WO1997005872A3 (en) | Use of 1h-1,2,4-triazole derivatives for inhibiting the growth of cancers | |
AP9801202A0 (en) | Atropisomers of 3-heteroaryl-4(3H)-quinazolinones. | |
AU3919001A (en) | Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers | |
GB9509888D0 (en) | Terpenoidic derivatives useful as antitumour agents | |
AU3600199A (en) | A pharmaceutical composition containing ezrin mutated on tyrosine 353 | |
YU46302A (sh) | Supstituisani piroli | |
MXPA02012209A (es) | Terapia combinada contra tumores que comprende derivados de bistamicina acriloilo substituida y agentes de alquilacion. | |
AP9801235A0 (en) | Erythromycin derivatives. |